Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates274,911주2026-06-30 · 증감 +68000주
- Viking Global Investors7,616,563주2026-06-30 · 증감 +554486주
BioMarin Pharmaceutical company information
바이오마린 파머슈티컬NASDAQ:BMRN · Nasdaq · Healthcare · sector #17$56.22-2.29%
2026-10-06 closeBioMarin Pharmaceutical's company information is shown as of 2026-10-06. It is a security listed on Nasdaq, ticker BMRN. There are 11 published related companies.
About this company
BioMarin Pharmaceutical last closed at $56.22 (-2.29%) on 2026-10-06. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- RocheCompetitor
희귀질환·효소대체요법 등에서 경쟁
- SanofiCompetitor
희귀질환/유전자·바이오의약 경쟁
- Takeda PharmaceuticalCompetitor
희귀질환 치료제 경쟁
- Vertex PharmaceuticalsCompetitor
유전성·희귀질환 치료 분야 경쟁
- Ultragenyx PharmaceuticalCompetitor
희귀질환 및 유전자치료 경쟁
- Sarepta TherapeuticsCompetitor
희귀 유전질환 치료제 경쟁
- Alexion PharmaceuticalsCompetitor
희귀질환 바이오의약 경쟁
- Bristol Myers SquibbRelated theme
희귀질환·유전자치료 바이오테마로 투자 연관
- Ionis PharmaceuticalsRelated theme
희귀 유전질환 RNA 기반 치료 테마
- AmgenCompetitor
희귀질환/바이오의약 전반에서 경쟁
- PfizerCompetitor
희귀질환 및 바이오의약 경쟁
Major stocks in the same sector
2026-10-07 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $3M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy